PMHNP CERTIFICATION QUESTION BANK: 200 AANP/ANCC-STYLE QUESTIONS COVERING EVERY EXAM TOPIC - PHARMACOLOGY, NEUROTRANSMITTERS, MENTAL HEALTH DISORDERS, TREATMENT MODALITIES, DIAGNOSTIC CRITERIA, AND PROFESSIONAL PRACTICE STANDARDS (2026 UPDATE)

PMHNP CERTIFICATION QUESTION BANK: 200 AANP/ANCC-STYLE QUESTIONS COVERING EVERY EXAM TOPIC - PHARMACOLOGY, NEUROTRANSMITTERS, MENTAL HEALTH DISORDERS, TREATMENT MODALITIES, DIAGNOSTIC CRITERIA, AND PROFESSIONAL PRACTICE STANDARDS (2026 UPDATE) 1. A patient on lithium therapy presents with vomiting, diarrhea, slurred speech, and a coarse hand tremor. Their lithium level is 1.3 mEq/L. What is the most appropriate initial action? A) Administer the next scheduled dose of lithium B) Hold the next dose and assess for signs of toxicity C) Increase the lithium dose to achieve therapeutic levels D) Prescribe an antiemetic and continue current dose Answer: B) Hold the next dose and assess for signs of toxicity Rationale: A lithium level of 1.3 mEq/L is above the therapeutic range (0.6-1.2 mEq/L). The patient is exhibiting signs of lithium toxicity including GI symptoms and neurological effects. The next dose should be held and the patient assessed for worsening symptoms. Levels above 3.0 mEq/L are considered a medical emergency. ________________________________________ 2. A patient prescribed Clozaril (clozapine) reports a sore throat and fever. Which lab value should the PMHNP prioritize checking? A) Serum creatinine B) Liver function tests C) Absolute neutrophil count (ANC) D) Serum glucose Answer: C) Absolute neutrophil count (ANC) Rationale: Clozaril carries a black box warning for agranulocytosis. Sore throat and fever are early signs of infection that could indicate a drop in white blood cell count. The ANC should be checked immediately. Discontinue if WBC 2000 or ANC 1000. ________________________________________ 3. A patient presents with cherry-colored urine, muscle rigidity, hyperthermia, and tachycardia after starting a new antipsychotic medication two weeks ago. What condition should the PMHNP suspect? A) Serotonin syndrome B) Neuroleptic malignant syndrome (NMS) C) Acute dystonia D) Tardive dyskinesia Answer: B) Neuroleptic malignant syndrome (NMS) Rationale: NMS typically has a slower onset (1-2 weeks after starting or changing therapy) and presents with muscle rigidity, hyperthermia, tachycardia, abnormal blood pressure, sweating, altered mental status, and cherry-colored urine (indicating rhabdomyolysis). NMS resolves within 9-14 days. ________________________________________ 4. Which of the following medication combinations would place a patient at highest risk for serotonin syndrome? A) Lithium and Depakote B) Fluoxetine and St. John's Wort C) Risperdal and Cogentin D) Lamictal and Tegretol Answer: B) Fluoxetine and St. John's Wort Rationale: Serotonin syndrome can be caused by combinations of serotonergic agents including antidepressants, St. John's Wort, Sam-E, Kava Kava, and Tryptophan. The combination of an SSRI like fluoxetine with St. John's Wort significantly increases serotonin levels and risk of serotonin syndrome. ________________________________________ 5. A patient on Depakote (valproic acid) reports right upper quadrant pain and dark brown urine. What lab test should the PMHNP order first? A) Serum amylase B) Liver function tests (LFTs) C) Complete blood count D) Serum valproic acid level Answer: B) Liver function tests (LFTs) Rationale: Right upper quadrant pain and dark brown urine are signs of hepatotoxicity, a serious adverse effect of Depakote. LFTs should be checked immediately to assess for liver damage. ________________________________________ 6. What fetal anomaly is associated with maternal lithium use during pregnancy? A) Spina bifida B) Cleft palate C) Epstein's anomaly D) Neural tube defects Answer: C) Epstein's anomaly Rationale: Lithium use during pregnancy is associated with Epstein's anomaly, a congenital heart defect affecting the tricuspid valve. This is a specific fetal side effect of lithium that requires counseling for women of childbearing age. ________________________________________ 7. A patient with treatment-resistant schizophrenia is being started on Clozaril. Which statement best describes a unique benefit of this medication? A) It has the lowest risk of metabolic syndrome B) It is the only antipsychotic that improves negative symptoms and reduces suicidal ideation C) It can be used without regular blood monitoring D) It has no risk of agranulocytosis Answer: B) It is the only antipsychotic that improves negative symptoms and reduces suicidal ideation Rationale: Clozaril is indicated for treatment-resistant schizophrenia and has unique benefits including improvement of negative symptoms and reduction of suicidal ideation. However, it requires regular blood monitoring due to risk of agranulocytosis. ________________________________________ 8. When prescribing Lamictal (lamotrigine) with Depakote (valproic acid), what dose adjustment is necessary? A) Increase Lamictal dose by 50% B) Decrease Lamictal dose by 50% C) No dose adjustment is needed D) Increase Depakote dose by 50% Answer: B) Decrease Lamictal dose by 50% Rationale: Depakote inhibits the metabolism of Lamictal, leading to increased lamotrigine levels. Therefore, the Lamictal dose should be decreased by 50% when used in combination with Depakote to reduce the risk of serious rash including Stevens-Johnson syndrome. ________________________________________ 9. Which two antipsychotics are considered weight-neutral with a low risk of metabolic side effects? A) Zyprexa and Seroquel B) Geodon and Abilify C) Risperdal and Clozaril D) Haldol and Thorazine Answer: B) Geodon and Abilify Rationale: Geodon (ziprasidone) and Abilify (aripiprazole) have very low weight-gaining effects compared to other atypical antipsychotics.